Effectiveness of the BNT162b2 mRNA COVID-19 Vaccine among Adolescents with Juvenile-onset Inflammatory Rheumatic Diseases.

Amit ZivMerav Heshin-BekensteinRuby HavivShaye KivityDoron NetzerShlomit YaronYoav SchurTsipi EgertYona EgertYaron SelaPhilip J HashkesYosef Uziel

Published in: Rheumatology (Oxford, England) (2022)

We found that the BNT162b2 mRNA vaccine is effective against COVID-19 infection in adolescents with IRD, similar to controls without immune rheumatic disease. Immunomodulatory therapy did not affect its effectiveness. These results can encourage adolescents with IRD to get vaccinated against COVID-19.

Keyphrases

coronavirus disease
sars cov
young adults
randomized controlled trial
physical activity
systematic review
rheumatoid arthritis
binding protein
respiratory syndrome coronavirus
oxidative stress
stem cells
bone marrow
smoking cessation